newsteelconstruction.com
NSC Archives
Search
Subscribe
Archives
Print Friendly, PDF & Email

Weekly News

New world-leading precision medicine campus set for Manchester

July 17, 2018 by NSC in Weekly News
Proposals have been announced to create a world-leading precision medicine campus in the Corridor Manchester Enterprise Zone.

Greater Manchester’s ground-breaking partnership between academia, industry and the NHS – Health Innovation Manchester – has been working with global diagnostics firm QIAGEN on a joint project which will create and support up to 1,500 jobs – adding almost £150M to Manchester’s economy over a decade.

The collaboration will also bring fast-tracked real health benefits to Manchester and Greater Manchester residents, and ultimately people nationally and internationally, through access to new tests and targeted treatments developed through pioneering research.

The proposals have been welcomed by Manchester and Greater Manchester civic, academic and health leaders.

The initial scheme will consist of a £25M new build that will deliver 8,500m² of Grade A lab and office space. Construction work will begin late 2018, with completion expected in 2020.

Sir Richard Leese, Leader of Manchester City Council, said: “This will help confirm Manchester as a world-leader in this vital emerging industry with enormous growth potential. This is an opportunity that as a city we cannot afford to miss. It’s a win-win – not just creating a raft of new highly skilled health science jobs and an economic boost but, crucially, also opening up revolutionary new health benefits for people here. Manchester’s future success depends on building on our distinctive strengths and life sciences definitely falls into that category.”

Mayor of Greater Manchester Andy Burnham said: “We’ve always led the way in Greater Manchester, whether it’s cutting edge science and technology, being at the forefront of social change, or pioneering partnerships across different sectors. The NHS was ‘born’ here in Greater Manchester in the middle of the 20th century, 70 years ago and last week we celebrated this. This week we secure our position in 21st century health innovation with this global deal.”

Rowena Burns, Chair of Health Innovation Manchester and Chair of Manchester Science Partnerships, said: “This is a hugely important step change for Greater Manchester’s already strong life sciences sector. The new health innovation campus, with QIAGEN at its heart, will support the continued growth of businesses which are driving the future shape of medicine and healthcare, and cement our position as a world-leader in precision medicine. This is precisely what Health Innovation Manchester was set up to do and, combined with our devolved health and social care system, places us in an incredibly strong position to address the health challenges of the population.”

Print Friendly, PDF & Email

Share this post